4 - imidazopyridazin- 1 -yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as Btk- inhibitors
摘要
The present invention relates to 6-5 membered fused pyridine ring compounds according to formula (I) or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds according to formula I in the treatment of Brutons Tyrosine Kinase (Btk) mediated disorders.
申请公布号
AU2012285987(A1)
申请公布日期
2014.02.06
申请号
AU20120285987
申请日期
2012.07.11
申请人
MERCK SHARP & DOHME B.V.
发明人
BARF, TJEERD A.;JANS, CHRISTIAAN GERARDUS JOHANNES MARIA;MAN, DE ADRIANUS PETRUS ANTONIUS;OUBRIE, ARTHUR A.;RAAIJMAKERS, HANS C A.;REWINKEL, JOHANNES BERNARDUS MARIA;STERRENBURG, JAN-GERARD;WIJKMANS, JACOBUS C.H.M.